The Medical Aesthetics Sector has reached a golden age, fueling an ultra blue-sky scenario in the consolidation momentum.
M&A dynamics in medical aesthetics is fueled by a conjunction of favorable factors: Rarity of high-quality targets with high entry tickets, Global competition of bidders for such assets, A strong capital market rally generated by injections of liquidities into the economy by major central banks (FED, ECB, BoJ) and the enthusiasm for tech and upscale goods, Access to key proprietary technologies and really innovative IP, Bidding wars leading to price optimization.
